What is Microbot Medical's warrants and rights outstanding?

Microbot Medical (MBOT) reported warrants and rights outstanding of 16.3M in Q1 2026.

What does warrants and rights outstanding mean?

The total number or value of warrants and rights issued by the company that grant holders the option to purchase shares at a specified price. These instruments represent potential future dilution to existing shareholders upon exercise. Monitoring this figure is crucial for calculating fully diluted share counts and assessing the company's long-term capital structure.

Microbot Medical MBOT Warrants and Rights Outstanding

Warrants and Rights Outstanding at other companies

RFL

Rafael Holdings, Inc.RFL

645.2K-39.1%

Other financials

Income statement

See full

Revenue$105.0K—

Gross profit$2.0K—

Operating income-$4.3M-43.0%

Net income-$3.7M-41.1%

EPS (diluted)-$0.05+37.5%

Balance sheet

See full

Cash & equivalents$3.7M+13.7%

Total debt$898.0K+551%

Total equity$74.1M+156%

Total assets$78.1M+153%

Cash flow

See full

Operating cash flow-$5.1M-75.8%

CapEx$108.0K+731%

Free cash flow-$5.2M-78.8%

Valuation

See full

Market cap$128.28M+36.1%

Enterprise value$125.53M+39.0%

P/S674.3×—

Profitability

See full

Operating margin25,292.9%—

Net margin-3,669.9%—

FCF margin-852.8%—

Returns & leverage

See full

Return on equity-27.6%-10.2pp

Debt / equity0×0.0×

Current ratio22.6×+6.4×

Where this comes from

Reported directly by Microbot Medical in its filing.

Tagged under the XBRL concept us-gaap:ClassOfWarrantOrRightOutstanding.

The official record: Microbot Medical’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Microbot Medical's warrants and rights outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Microbot Medical's warrants and rights outstanding?: Microbot Medical (MBOT) reported warrants and rights outstanding of 16.3M in Q1 2026.
What does warrants and rights outstanding mean?: The total number or value of warrants and rights issued by the company that grant holders the option to purchase shares at a specified price. These instruments represent potential future dilution to existing shareholders upon exercise. Monitoring this figure is crucial for calculating fully diluted share counts and assessing the company's long-term capital structure.